Ben Ho Park

Ben Ho Park, M.D., Ph.D., is a Professor of Medicine at Vanderbilt University School of Medicine and holds the Donna S. Hall Chair in Breast Cancer. He serves as Co-Leader of the Breast Cancer Research Program, Associate Director for Translational Research, and Director of Precision Oncology at the Vanderbilt-Ingram Cancer Center (VICC). He is also Associate Director for Basic and Translational Research in the Division of Hematology and Oncology within the Department of Medicine.

• Undergraduate: University of Chicago (1989, with honors)
• M.D., Ph.D.: University of Pennsylvania School of Medicine (1995)
• Residency: Internal Medicine, Hospital of the University of Pennsylvania
• Fellowship: Hematology/Oncology, Hospital of the University of Pennsylvania
• Postdoctoral Fellowship: Cancer Genetics, Johns Hopkins University (Laboratory of Dr. Bert Vogelstein)

Dr. Park’s research is centered on identifying mutated and altered genes involved in the development, progression, and drug resistance of breast cancer. His work bridges basic science and clinical application through active collaboration with the VICC’s clinical research team, aiming to translate genomic discoveries into improved patient care. His expertise lies in cancer genetics, precision oncology, and translational research.

While no specific publications are listed in the provided text, Dr. Park’s research focus indicates a strong trajectory in molecular oncology, particularly in genomic alterations in breast cancer and mechanisms of therapeutic resistance. His work likely spans genomics, tumor evolution, biomarker discovery, and targeted therapies.

Dr. Park has held significant leadership roles in research training and education, including Associate Dean for Postdoctoral Affairs at Johns Hopkins School of Medicine and Associate Director for Research Training and Education at the Johns Hopkins Cancer Center. Though no specific grants are mentioned, his leadership positions and research program suggest substantial external funding and mentorship of trainees.

Dr. Park is actively involved with the Breast Cancer Research Program at VICC, which functions as his primary research team. The program integrates basic, translational, and clinical researchers focused on eradicating breast cancer through innovative science and patient-centered care.